Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0P6CN
|
||||
| Former ID |
DIB004381
|
||||
| Drug Name |
XR-368
|
||||
| Synonyms |
Xenovulene; XR-7009
|
||||
| Indication | Anxiety disorder [ICD9: 300, 311; ICD10:F32, F40-F42] | Terminated | [1] | ||
| Company |
Xenova Ltd
|
||||
| Structure |
|
Download2D MOL |
|||
| Canonical SMILES |
C12=C(C(=O)[C@@H]3[C@H]1[C@H]([C@H]1[C@](O2)(C/C=C/C(C/<br />C=C(/CC1)\C)(C)C)C)OC3)O
|
||||
| Target and Pathway | |||||
| Target(s) | Gamma-aminobutyric acid receptor | Target Info | Modulator | [2] | |
| References | |||||
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800004007) | ||||
| REF 2 | Regulation of neuronal and recombinant GABA(A) receptor ion channels by xenovulene A, a natural product isolated from Acremonium strictum. J Pharmacol Exp Ther. 1997 Aug;282(2):513-20. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.